or
Johnson & Johnson Consumer, Michel De Braeystraat 52,
Antwerpen, 2000, Belgica.
or
Johnson & Johnson GmbH, Johnson & Johnson Platz 2, 41470 Neuss, Germany
This medicine is authorized in the following EU countries under the following denominations:
Belgium:Imodium Duo 2mg/125mg Tablets
Bulgaria:Imodium Plus 2mg/125mg Caplets
Cyprus:Imodium Plus
Czech Republic:Imodium Plus
Denmark:Imodium Plus
Finland:Imodium Plus Tablets
France:Imodiumduo Tablet
Germany:Imodium Akut Duo
Greece:Imodium Plus
Hungary:Imodium Plus 2 mg/125 mg tablet
Ireland:Imodium Plus 2 mg/125 mg tablet
Luxembourg:Imodium Duo 2 mg/125 mg Tablets
Netherlands:Imodium Duo 2 mg/125, tablets
Norway:Imodium Comp
Portugal:Imodium Plus 2 mg/125 mg Tablets
Romania:Imodium Plus 2mg/125mg tablets
Slovakia:Imodium Plus
Spain:Fortasec plus 2 mg/125 mg Tablets
Sweden:Imodium Plus 2 mg/125 mg tablet
United Kingdom (Northern Ireland) :ImodiumDual Action Relief Tablets
This leaflet has been reviewed in April 2023
The detailed and updated information of this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.